Clear Street LLC Invests $1.88 Million in Kala Pharmaceuticals, Inc. (NASDAQ:KALA)

Clear Street LLC acquired a new position in shares of Kala Pharmaceuticals, Inc. (NASDAQ:KALA – Get Rating) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 49,390 shares of the company’s stock, valued at approximately $1,884,000. Kala Pharmaceuticals comprises about 0.0% of Clear Street […]

Related Keywords

,Justin Hanes ,Roberts Langer ,Kala Pharmaceuticals ,Renaissance Technologies ,Mirabella Financial Services ,Wealth Concepts ,Kala Pharmaceuticals Profile ,Kala Pharmaceuticals Stock Down ,Columbus Asset Advisors ,Quarter For Kala Pharmaceuticals ,Kala Pharmaceuticals Inc ,Nasdaq ,Goldman Sachs Group Inc ,News Ratings For Kala Pharmaceuticals Daily ,Clear Street ,Get Rating ,Financial Services ,Sachs Group ,Integrated Wealth Concepts ,Pharmaceuticals Stock Down ,Kala Pharmaceuticals Daily ,Nasdaq Kala ,Bkala ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,